FDA grants IND clearance for Spinogenix’s ALS treatment trial

FDA grants IND clearance for Spinogenix’s ALS treatment trial

Submitted by admin on May 30, 2024 - 11:13am
Source: 
Clinical Trials Arena
News Tags: 
Spinogenix
ALS
clinical trials
SPG302
FDA
Headline: 
FDA grants IND clearance for Spinogenix’s ALS treatment trial
snippet: 

The US Food and Drug Administration (FDA) has granted clearance for Spinogenix’s investigational new drug (IND) application for the Phase I/II clinical trial of SPG302, a new therapy aimed at treating amyotrophic lateral sclerosis (ALS).

Do Not Allow Advertisers to Use My Personal information